Page last updated: 2024-09-04

torcetrapib and Obesity

torcetrapib has been researched along with Obesity in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Burnier, M; Vogt, B	1
André, A; Briand, F; Ouguerram, K; Sulpice, T; Thieblemont, Q	1

Reviews

1 review(s) available for torcetrapib and Obesity

Article	Year
Aldosterone and cardiovascular risk. Current hypertension reports, 2009, Volume: 11, Issue:6 Topics: Aldosterone; Antihypertensive Agents; Cardiovascular Diseases; Cholesterol Ester Transfer Proteins; Humans; Hyperaldosteronism; Kidney Diseases; Metabolic Syndrome; Obesity; Quinolines	2009

Other Studies

1 other study(ies) available for torcetrapib and Obesity

Article	Year
CETP inhibitor torcetrapib promotes reverse cholesterol transport in obese insulin-resistant CETP-ApoB100 transgenic mice. Clinical and translational science, 2011, Volume: 4, Issue:6 Topics: Animals; Anticholesteremic Agents; Apolipoprotein B-100; Bile Acids and Salts; Biological Transport; Body Weight; Cells, Cultured; Cholesterol; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Dyslipidemias; Humans; Insulin Resistance; Lipoproteins; Macrophages; Male; Mice; Mice, Transgenic; Obesity; Quinolines	2011

Article

Year

CETP inhibitor torcetrapib promotes reverse cholesterol transport in obese insulin-resistant CETP-ApoB100 transgenic mice.

Clinical and translational science, 2011, Volume: 4, Issue:6

Topics: Animals; Anticholesteremic Agents; Apolipoprotein B-100; Bile Acids and Salts; Biological Transport; Body Weight; Cells, Cultured; Cholesterol; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Dyslipidemias; Humans; Insulin Resistance; Lipoproteins; Macrophages; Male; Mice; Mice, Transgenic; Obesity; Quinolines

2011